Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Wharton S, Blevins T, Connery L, Rosenstock J, et al. N Engl J Med 2023 Jun 23. doi: 10.1056/NEJMoa2302392.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wharton S, Blevins T, Connery L, Rosenstock J, et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med 2023 Jun 23. doi: 10.1056/NEJMoa2302392.
PMID: 37351564